EQUINOX NEPREMICNINE d.d Past Earnings Performance
Past criteria checks 3/6
EQUINOX NEPREMICNINE d.d has been growing earnings at an average annual rate of 22.1%, while the Real Estate industry saw earnings growing at 3.8% annually. Revenues have been growing at an average rate of 6% per year. EQUINOX NEPREMICNINE d.d's return on equity is 2.2%, and it has net margins of 11.2%.
Key information
22.1%
Earnings growth rate
22.1%
EPS growth rate
| Real Estate Industry Growth | 7.5% |
| Revenue growth rate | 6.0% |
| Return on equity | 2.2% |
| Net Margin | 11.2% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How EQUINOX NEPREMICNINE d.d makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 8 | 1 | 0 | 0 |
| 31 Mar 23 | 8 | 1 | 0 | 0 |
| 31 Dec 22 | 7 | 1 | 0 | 0 |
| 31 Dec 21 | 7 | 1 | 0 | 0 |
Quality Earnings: EQNX has high quality earnings.
Growing Profit Margin: EQNX's current net profit margins (11.2%) are higher than last year (9.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if EQNX's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare EQNX's past year earnings growth to its 5-year average.
Earnings vs Industry: EQNX earnings growth over the past year (22.1%) exceeded the Real Estate industry -25.9%.
Return on Equity
High ROE: EQNX's Return on Equity (2.2%) is considered low.